The bill amends sections 3313.718 and 3314.141 of the Revised Code to allow students in Ohio schools, including chartered nonpublic schools, to possess and use nasal epinephrine delivery devices, in addition to epinephrine autoinjectors, for the treatment of anaphylaxis. The amendments specify that students must have written approval from a prescriber and, if they are minors, from a parent or guardian. The prescriber's approval must include detailed information about the student, the medication, and instructions for use, as well as emergency contact numbers. Schools are required to have copies of these approvals and a backup dose of the medication.

Additionally, the bill provides liability protections for school districts and employees regarding the use of these devices. It states that they are not liable for any harm resulting from their decisions to allow or prohibit a student from using an autoinjector or nasal device based on their good faith belief regarding compliance with the conditions set forth in the bill. The bill also repeals existing sections 3313.718 and 3314.141, effectively replacing them with the new provisions.

Statutes affected:
As Introduced: 3313.718, 3314.141